|
Committees
Executive Committee
Members
| Dr D. ALKER (David Alker Associates, Birchington, United Kingdom) |
| Dr C. CONTINO-PEPIN (University of Avignon, Avignon, France) |
| Dr P. GEORGE (SCT & Independent Scientific Expert & Adviser, Longvilliers, France) |
| Prof. X. PANNECOUCKE (INSA Rouen, Saint Etienne du Rouvray, France) |
| Prof. S. ROUTIER (Université d'Orléans, Orléans, France) |
| Prof. J. SAPI (SCT & University of Reims-Champagne-Ardenne, Reims, France) |
| Dr L. VAN HIJFTE (SCT & NovAliX, Nijmegen, The Netherlands) |
| Prof. H. VAUDRY (University of Rouen, Mont-Saint-Aignan, France) |
Local Organising Committee
Members
| Prof. T. BESSON (University of Rouen, COBRA-IRCOF, Rouen, France) |
| Prof. J.-P. BOUILLON (University of Rouen, Mont Saint Aignan, France) |
| Mrs N. DOUMENG (Technopole Chimie-Biologie-Santé, Val de Reuil, France) |
| Prof. X. PANNECOUCKE (INSA Rouen, Saint Etienne du Rouvray, France) |
| Dr D. VAUDRY (University of Rouen, Mont-Saint-Aignan, France) |
| Prof. H. VAUDRY (University of Rouen, Mont-Saint-Aignan, France) |
Scientific Advisory Board
Members
| Prof. F. ALBERICIO (Institute for Research in Biomedicine, Durban , South Africa) |
| Prof. K.-H. ALTMANN (SCS DMCCB & Swiss Federal Institute of Technology, Zürich, Switzerland) |
| Dr A. BARON (Edelris, Bristol, United Kingdom) |
| Dr F. BEAULIEU (Omegachem, Québec, Canada) |
| Dr A. BECK (Pierre Fabre, St Julien-en-Genevois, France) |
| Dr C. BERTRAND (Ipsen, Les Ulis, France) |
| Dr L. CASTRO (UCB, Slough, United Kingdom) |
| Prof. A. CHARETTE (University of Montreal, Montreal, Canada) |
| Prof. S. CHOI (Ewha Womans University, Seoul, Korea, South) |
| Mr K. DACK (Leo Pharma, Ballerup, Denmark) |
| Prof. P. DALLEMAGNE (University of Caen, Caen, France) |
| Dr E. DEMONT (GSK, Stevenage, United Kingdom) |
| Prof. G. ECKER (University of Vienna, Vienna, Austria) |
| Dr R. GOSMINI (NovAliX, llkirch-Graffenstaden, France) |
| Dr A. HALL (Eisai, Hertfordshire, United Kingdom) |
| Dr H. HASHIMOTO (Japan Tobacco, Takatsuki, Japan) |
| Dr C. HEDGECOCK (Uppsala University, Consultant DiversiQuem, Uppsala, Sweden) |
| Prof. A. P. IJZERMAN (Leiden University, Leiden, The Netherlands) |
| Dr K. KATAOKA (Teijin Pharma Limited, Tokyo, Japan) |
| Dr F. LEEMHUIS (Mercachem-Syncom, Nijmegen, The Netherlands) |
| Dr I. LEWIS (Novartis, Basel, Switzerland) |
| Prof. J. MARTINEZ (University of Montpellier, Montpellier, France) |
| Dr V. MIKOL (Sanofi, Vitry-sur-Seine, France) |
| Prof. P. MONSAN (INSA, Toulouse, France) |
| Dr H. PRIEPKE (Boehringer-Ingelheim, Ingelheim, Germany) |
| Prof. J. REICHERT (Tufts University, Boston, United States) |
| Dr H. SCHIROK (Bayer, Wuppertal, Germany) |
| Dr P. SENECI (University of Milan, Milan, Italy) |
| Prof. W. SIPPL (Martin-Luther-Universität Halle-Wittenberg, Halle, Germany) |
| Dr J.-P. SURIVET (Actelion, Allschwil, Switzerland) |
| Dr M. TANAKA (Daiichi Sankyo RD Novare, Tokyo, Japan) |
| Dr G. TANG (Roche, Shanghai, China) |
| Dr A. TORRENS (Esteve Pharmaceuticals, Barcelona, Spain) |
| Dr K. VAN EMELEN (Janssen, Beerse, Belgium) |
| Dr K. ZHANG (RIKEN, Yokohama, Japan) |
|
Organised by
With the support of
Major Sponsor
Media Partner
|